Shanghai Fosun Pharmaceutical (Group) Co Ltd (SFOSF)
1.695
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Shanghai Fosun Pharmaceutical Gross Profit Margin (Quarterly): 50.01% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 50.01% |
| December 31, 2023 | 45.64% |
| September 30, 2023 | 45.39% |
| June 30, 2023 | 48.66% |
| March 31, 2023 | 51.29% |
| December 31, 2022 | 49.25% |
| September 30, 2022 | 48.09% |
| June 30, 2022 | 47.86% |
| March 31, 2022 | 43.55% |
| December 31, 2021 | 44.88% |
| September 30, 2021 | 46.71% |
| June 30, 2021 | 50.86% |
| March 31, 2021 | 51.78% |
| December 31, 2020 | 51.50% |
| September 30, 2020 | 56.18% |
| June 30, 2020 | 56.10% |
| March 31, 2020 | 55.13% |
| December 31, 2019 | 59.13% |
| September 30, 2019 | 58.36% |
| June 30, 2019 | 61.73% |
| March 31, 2019 | 59.12% |
| December 31, 2018 | 58.75% |
| September 30, 2018 | 58.23% |
| June 30, 2018 | 58.95% |
| March 31, 2018 | 57.59% |
| Date | Value |
|---|---|
| December 31, 2017 | 60.23% |
| September 30, 2017 | 60.49% |
| June 30, 2017 | 58.89% |
| March 31, 2017 | 55.34% |
| December 31, 2016 | 54.82% |
| September 30, 2016 | 54.43% |
| June 30, 2016 | 55.04% |
| March 31, 2016 | 51.64% |
| December 31, 2015 | 48.26% |
| September 30, 2015 | 50.84% |
| June 30, 2015 | 51.62% |
| March 31, 2015 | 49.31% |
| December 31, 2014 | 46.10% |
| September 30, 2014 | 44.96% |
| June 30, 2014 | 43.36% |
| March 31, 2014 | 41.49% |
| December 31, 2013 | 45.80% |
| September 30, 2013 | 43.65% |
| June 30, 2013 | 44.08% |
| March 31, 2013 | 44.44% |
| December 31, 2012 | 42.57% |
| September 30, 2012 | 43.47% |
| June 30, 2012 | 44.01% |
| March 31, 2012 | 45.32% |
| December 31, 2011 | 42.05% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
43.55%
Minimum
Mar 2022
61.73%
Maximum
Jun 2019
51.11%
Average
50.43%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 52.98% |
| Zai Lab Ltd | 61.42% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.58% |
| Return on Assets | 1.80% |
| Return on Invested Capital | 2.27% |
| Profit Margin (Quarterly) | 6.00% |
| Operating Margin (Quarterly) | 9.81% |
| Return on Net Operating Assets | 2.93% |